Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Germano Perotti; Chiara De Waure; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Monica Santimaria; Annibale Versari; Stefano Fanti; Silvia Fanti; Aldo Giordano; Vittoria Rufini

doi:10.1007/s00259-011-2031-6

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Giorgio Treglia, Paola Castaldi, Maria Felicia Villani, Germano Perotti, Chiara De Waure, Angelina Filice, Valentina Ambrosini, Nadia Cremonini, Monica Santimaria, Annibale Versari, Stefano Fanti, Silvia Fanti, Aldo Giordano, Vittoria Rufini

Research output: Contribution to journal › Article

90 Citations (Scopus)

Abstract

To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.

Original language	English
Pages (from-to)	569-580
Number of pages	12
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	39
DOIs	https://doi.org/10.1007/s00259-011-2031-6
Publication status	Published - 2012

Keywords

PET tracers
imaging
medullary thyroid carcinoma

Access to Document

10.1007/s00259-011-2031-6

Cite this

Treglia, G., Castaldi, P., Villani, M. F., Perotti, G., De Waure, C., Filice, A., Ambrosini, V., Cremonini, N., Santimaria, M., Versari, A., Fanti, S., Fanti, S., Giordano, A., & Rufini, V. (2012). Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 39, 569-580. https://doi.org/10.1007/s00259-011-2031-6

@article{77cd283ced5e4007bf82f1488ad4873d,

title = "Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma",

abstract = "To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.",

keywords = "PET tracers, imaging, medullary thyroid carcinoma, PET tracers, imaging, medullary thyroid carcinoma",

author = "Giorgio Treglia and Paola Castaldi and Villani, {Maria Felicia} and Germano Perotti and {De Waure}, Chiara and Angelina Filice and Valentina Ambrosini and Nadia Cremonini and Monica Santimaria and Annibale Versari and Stefano Fanti and Silvia Fanti and Aldo Giordano and Vittoria Rufini",

year = "2012",

doi = "10.1007/s00259-011-2031-6",

language = "English",

volume = "39",

pages = "569--580",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

}

Treglia, G, Castaldi, P, Villani, MF, Perotti, G, De Waure, C, Filice, A, Ambrosini, V, Cremonini, N, Santimaria, M, Versari, A, Fanti, S, Fanti, S, Giordano, A & Rufini, V 2012, 'Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma', European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, pp. 569-580. https://doi.org/10.1007/s00259-011-2031-6

TY - JOUR

T1 - Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

AU - Treglia, Giorgio

AU - Castaldi, Paola

AU - Villani, Maria Felicia

AU - Perotti, Germano

AU - De Waure, Chiara

AU - Filice, Angelina

AU - Ambrosini, Valentina

AU - Cremonini, Nadia

AU - Santimaria, Monica

AU - Versari, Annibale

AU - Fanti, Stefano

AU - Fanti, Silvia

AU - Giordano, Aldo

AU - Rufini, Vittoria

PY - 2012

Y1 - 2012

N2 - To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.

AB - To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.

KW - PET tracers

KW - imaging

KW - medullary thyroid carcinoma

KW - PET tracers

KW - imaging

KW - medullary thyroid carcinoma

UR - http://hdl.handle.net/10807/25077

U2 - 10.1007/s00259-011-2031-6

DO - 10.1007/s00259-011-2031-6

M3 - Article

SN - 1619-7070

VL - 39

SP - 569

EP - 580

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this